Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease

Article Abstract:

A mouse model of Alzheimer's disease is presented.

Author: Games, Dora, Chen, Guiquan, Chen, Karen S., Knox, Jane, Inglis, Jennifer, Bernard, Andrew, Martin, Stephen J., Justice, Alan, McConlogue, Lisa, Freedman, Stephen B., Morris, Richard G.M.
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein

Article Abstract:

Transgenic mice that overexpress human mutant beta-amyloid precursor protein exhibit symptoms of Alzheimer's disease (AD) such as synaptic loss, neuritic plaques, astrocytosis and microgliosis. In this mutant protein, a phenylalanine replaces valine in the 717 residue. These data suggest a role for such transgenic mice in testing drugs for AD treatment.

Author: Donaldson, Thomas, Barbour, Robin, Games, Dora, Carr, Tony, Adams, David, Alessandrini, Ree, Berthelette, Patricia, Blackwell, Catherine, Clemens, James, Gillespie, Frances
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1995
Analysis, Proteins, Genetically modified mice

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Article Abstract:

Immunization with A-beta-42, the 42-amino-acid form of amyloid-beta peptide, prevents the development of Alzheimer's disease-like neuropathology in PDAPP transgenic mice, which overexpress mutant human amyloid precursor protein. In these mice, immunization with A-beta-42 disrupts a key mechanism of amyloid plaque formation. Immunization either prevents deposition and/or boosts the clearance of A-beta from the brain. It is likely that a similar reduction of neuropathology in Alzheimer's disease patients would be clinically beneficial.

Author: Barbour, Robin, Games, Dora, Grajeda, Henry, Guido, Teresa, Hu, Kang, Huang, Jiping, Khan, Karen, Kholodenko, Dora, Lee, Mike, Lieberburg, Ivan, Motter, Ruth, Vasquez, Nicki, Schenk, Dale, Yednock, Ted, Seubert, Peter, Johnson-Wood, Kelly, Dunn, Whitney, Gordon, Grace, Liao, Zhenmei, Mutter, Linda, Soriano, Ferdi, Shopp, George, Vandevert, Christopher, Walker, Shannan, Wogulis, Mark
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1999
Amyloidosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Alzheimer's disease
Similar abstracts:
  • Abstracts: Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Subunits beta-gamma of heterotrimeric G protein activate beta-2 isoform of phospholipase C
  • Abstracts: Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA
  • Abstracts: Evolution and transmission of stable CTL escape mutations in HIV infection. Immune control of HIV-1 after early treatment of acute infection
  • Abstracts: Chemically mediated predator inspection behavior in the absence of predator visual cues by a characin fish. Who dares, learns: Chemical inspection behaviour and acquired predator recognition in a characin fish
  • Abstracts: Experimental evidence that group foragers can converge on predicted producer-scrounger equilibria. Head position as an indicator of producer and scrounger tactics in a ground-feeding bird
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.